Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation.

Clin Dev Immunol · 2012 · PMC3514826 · PMID 23227090

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Further analysis of recipient peripheral blood serum showed a trend toward increased TGF- β 1 levels in MSC-treated groups, as compared to control groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.